SEC Form 4 · accession 0001209191-19-007170
Genprex, Inc. · GNPX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Rodney Varner
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Nov 2, 2018
Accepted (ET)
Feb 5, 2019 · 11:07 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001595248
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.15 | Nov 2, 2018 | A | 551,284 | A | Nov 2, 2018 | Nov 2, 2028 | Common Stock | 551,284 | 551,284 | D |
Explanation of responses
- F1One hundred percent (100%) of the Shares subject to the Option shall vest upon the date of grant of the Option.
Remarks
A Form 4 to disclose this transaction was filed on November 6, 2018. In that filing, Genprex's CCC code, rather than the filing person's CCC code, was used inadvertently. As a result, the filing appeared in EDGAR under Genprex's name only, and not under the filing person's name. This Form 4 is being filed using the filing person's CCC code in order to correct the error.